Esoteric Testing Market: Current Analysis and Forecast (2021-2027)
August 2021
218
About the Report
About the Report
Esoteric testing is the examination of uncommon chemicals or molecules that are not detected in conventional clinical laboratory tests. Endocrinology, genetics, immunology, microbiology, molecular diagnostics, oncology, serology, and toxicology are some of the areas where esoteric testing is performed. In-house esoteric testing is usually outsourced to independent and specialized clinical reference laboratories.
Over the forecast period, the market will be driven by an increase in the frequency of rare and complex diseases, as well as increased awareness about early disease detection and treatment. According to the European Commission, rare diseases affect nearly 27 to 36 million individuals throughout Europe. The rapidly growing healthcare sector in developing countries, as well as an increase in the number of sophisticated laboratories providing advanced services, will help the industry flourish. The growing number of baby boomers who are susceptible to a variety of chronic illnesses will have a significant impact on industry growth. North America and Asia-Pacific would be the top two markets for Esoteric Testing, owing to the increasing patient population suffering from chronic diseases and rising increased adoption of rapid diagnostics. Based on type the global Esoteric Testing market is bifurcated into infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. Currently, the infectious diseases testing segment dominates the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.
Based on technology the market is divided into Power line chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, flow cytometry, radioimmunoassay, and others. The chemiluminescence immunoassay segment dominated the market in 2020 owing to its advantages over other testing methods, such as high-performance levels, low detection limits; etc.
Based on end-user the market is bifurcated into independent & reference laboratories, research laboratories, and hospital-based laboratories. Currently independent & reference laboratories segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the presence of improved diagnostic equipment and devices.
For a better understanding of the market adoption, the report provides detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for esoteric testing owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.
Some of the major players operating in the market include LabCorp, Quest Diagnostics, Invitae Corporation, Mayo Medical Laboratories, Spectra Laboratories, Opko Health, Miraca Holdings, Foundation Medicine, Myriad Genetics, and Sonic Healthcare.
Global Esoteric Testing Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Esoteric Testing Market is expected to witness a boost on account of the increasing prevalence of rare and infectious diseases.
Products
Companies
LabCorp
Quest Diagnostics
Invitae Corporation
Mayo Medical Laboratories
Spectra Laboratories
Opko Health
Miraca Holdings
Foundation Medicine
Myriad Genetics
and Sonic Healthcare
Table of Contents
Table of Contents
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Esoteric Testing Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Esoteric Testing Market
2.1.1 Main Objective of the Global Esoteric Testing Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPs UNDER ESOTERIC TESTING INDUSTRY
6 COVID-19 IMPACT
7 GLOBAL ESOTERIC TESTING MARKET REVENUE
8 MARKET INSIGHTS BY TYPES
8.1 Infectious Diseases Testing
8.2 Endocrinology Testing
8.3 Oncology Testing
8.4 Genetic Testing
8.5 Toxicology Testing
8.6 Immunology Testing
8.7 Neurology Testing
9 MARKET INSIGHTS BY TECHNOLOGY
9.1 Chemiluminescence Immunoassay
9.2 Enzyme-Linked Immunosorbent Assay
9.3 Mass Spectrometry
9.4 Real-Time PCR
9.5 Flow Cytometry
9.6 Radioimmunoassay
9.7 Others
10 MARKET INSIGHTS BY END-USER
10.1 Independent & Reference Laboratories
10.2 Research Laboratories
10.3 Hospital based laboratories
11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA ESOTERIC TESTING MARKET
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 EUROPE ESOTERIC TESTING MARKET
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Spain
11.2.5 Italy
11.2.6 Rest of Europe
11.3 ASIA PACIFIC ESOTERIC TESTING MARKET
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.6 Rest of Asia Pacific
11.4 REST OF THE WORLD ESOTERIC TESTING MARKET
12 ESOTERIC TESTING MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY SIDE ANALYSIS
14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
15 VALUE CHAIN ANALYSIS
16 ESOTERIC TESTING MARKET OPPORTUNITIES
17 ESOTERIC TESTING MARKET TRENDS & INSIGHTS
18 COMPETITIVE SCENARIO
18.1 Porter's Five forces analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
19 COMPANY PROFILED
19.1 Myriad Genetics
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Key Product/Services Offerings
19.1.4 Growth Strategy
19.1.5 SWOT Analysis
19.1.6 Key Financials
19.1.6.1 Revenue Split
19.1.6.2 Financial Overview of Medtronics plc
19.1.7 Recent Developments
19.1.7.1 Product Launch
19.1.7.2 Partnerships
19.1.7.3 Business Expansion and Investments
19.1.7.4 Merger and Acquisition
19.2 LabCorp
19.3 Quest Diagnostics
19.4 Invitae Corporation
19.5 Mayo Medical Laboratories
19.6 Spectra Laboratories
19.7 Opko Health
19.8 Miraca Holdings
19.9 Foundation Medicine
19.10 Sonic Healthcare
20 DISCLAIMER
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.